/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | CELZCREATIVE MEDICAL TEC |
|---|---|
| Last close | $0.61close 2026-11-09 |
| Change % | -1.59%close 2026-11-09 |
| Market cap | $5Mclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $6000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-12-31 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -45.5%FY to 2025-12-31 |
| Net income | $-5995008⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 Filing10-K · 0001477932-26-001517 · filed 2026-03-20 Open the filing on EDGAR →Open the XBRL payload →CiteCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ), us-gaap:NetIncomeLoss: -5,995,008 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001477932-26-001517, filed 2026-03-20. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001187953/us-gaap/NetIncomeLoss.json |
| Net margin | -99916.8%FY to 2025-12-31 |
| EPS (diluted) | $-2.52⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001477932-26-001517 · filed 2026-03-20 Open the filing on EDGAR →Open the XBRL payload →CiteCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ), us-gaap:EarningsPerShareDiluted: -2.52 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001477932-26-001517, filed 2026-03-20. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001187953/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-12-31 |
| Altman Z-ScoreUNVALIDATED | -4.36FY to 2025-12-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | — |